Evercore ISI initiated coverage of Repligen (RGEN) with an In Line rating and $155 price target The firm sees the company as a high quality ...

Micro Bioreactor System Market is Segmented by Type (48 Parallel, 24 Parallel), by Application (Pharmaceutical, Sewage Treatment, Biochemical Engineering, Food Industry).

Does a claim that merely recites an inherent property of an otherwise obvious claim require an additional analysis to demonstrate that a person ...

Researchers from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences ...

Sartorius invests in new production line in Bengaluru to meet global demands, doubling capacity for chromatography systems.

Prof Mark Smales, a principal investigator at NIBRT, has received more than €3.5m from Research Ireland to advance biotheraupeutics.

Sartorius Aktiengesellschaft (OTCMKTS:SOAGY – Get Free Report) traded up 8.3% during trading on Wednesday . The stock traded as high as $50.58 and last traded at $50.58. 5,353 shares changed hands ...

The global market for single-use bioprocessing probes and sensors is experiencing a robust growth trajectory, driven by ...

Repligen Corp. acquired 908 Devices Inc.’s desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications for $70 million in cash.

The monetary consideration of Repligen's purchase of 908 Devices' bioprocess analytics portfolio is a payment of $70 million in cash.

Repligen Corporation acquired 908 Devices’ desktop portfolio of 4 devices for bioprocessing process analytical technology (PAT) applications.

Devices (MASS) stock soars 71% premarket as Repligen (RGEN) announces $70M acquisition of its bioprocessing analytics ...